GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of anyone else notice GIP kicking in around week 81 — 27 comments in the full submission. View in context.
882
c/tirzepatide·submitted 1 year ago by u/elin_varga

anyone else notice GIP kicking in around week 81

Titrationbranch of 12 comments

anyone else notice GIP kicking in around week 81, logged the same way every week so the comparison is at least internally fair. Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it. The distribution matters more than the mean. In the trial…

Read the full submission and all 27 comments →

This branch

12 comments, started 1 year ago
u/quiet_moderatormod18 points·1 year ago

week 6 is early to draw any conclusion at all

replysharereportpermalink
u/sofia_nascimento9 points·1 year ago·edited

week 6 is early to draw any conclusion at all

Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.

replysharereportpermalink
u/forest_plot_fionastats5 points·1 year ago

Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.

replysharereportpermalink
u/mikkel_kimani3 points·1 year ago

the trials titrated on a calendar, real people titrate on symptoms

replysharereportpermalink
u/ferran_mensah1 point·1 year ago

stepping every four weeks is a ceiling on speed, not a schedule you must hit

replysharereportpermalink
u/graph_it_gary12 points·1 year ago

Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.

replysharereportpermalink
[deleted]5 points·1 year ago

[deleted]

replysharereportpermalink
load more comments (5) →

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.